Time-dependent effect of oligomeric amyloid-β (1–42)-induced hippocampal neurodegeneration in rat model of Alzheimer’s disease

References

• Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41:1088–1093.
   PubMed Web of Science ®Google Scholar
• Periyasamy S, Sathya M, Karthick C, et al. Association studies of specific cholesterol related genes (APOE, LPL,and CETP) with lipid profile and memory function: a correlative study among rural and tribal population of Dharmapuri district, India. J Alzheimer’s Dis. 2017:S195–S207. DOI:10.3233/JAD-170272
   PubMed Web of Science ®Google Scholar
• Oda T, Wals P, Osterburg HH, et al. Clusterin (ApoJ) alters the aggregation of amyloid β-peptide (Aβ1–42) and forms slowly sedimenting Aβ complexes that cause oxidative stress. Exp Neurol. 1995;136:22–31.
   PubMed Web of Science ®Google Scholar
• Marr RA, Hafez DM. Amyloid-beta and Alzheimer’s disease: the role of neprilysin-2 in amyloid-beta clearance. Front Aging Neurosci. 2014;6. DOI:10.3389/fnagi.2014.00187.
   Web of Science ®Google Scholar
• Sun X, Chen WD and Wang YD. β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease. Front Pharmacol. 2015;6:221.
   PubMed Web of Science ®Google Scholar
• Tanzi RE, Bertram L. Twenty years of the Alzheimer’s disease amyloid hypothesis: a genetic perspective. Cell. 2005;120:545–555.
   PubMed Web of Science ®Google Scholar
• Hyman BT, Van Hoesen GW, Damasio AR, et al. Alzheimer’s disease: cell specific pathology isolates the hippocampal formation. Science. 1984;225:1168–1170.
   PubMed Web of Science ®Google Scholar
• Wallenstein GVH, Hasselmo ME. The hippocampus as an associator of discontinuous events. Trends Neurosci. 1998;21:317–323.
   PubMed Web of Science ®Google Scholar
• Palop JJ, Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks. Nat Neurosci. 2010;13(7):812–818.
   PubMed Web of Science ®Google Scholar
• Sebollela A, Freitas-Correa L, Oliveira FF, et al. Amyloid-β oligomers induce differential gene expression in adult human brain slices. J Biol Chem. 2012;287:7436–7445.
   PubMed Web of Science ®Google Scholar
• Mucke L, Selkoe DJ. Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med. 2012;2(7):a006338.
   PubMed Web of Science ®Google Scholar
• Palop JJ, Chin J, Roberson ED, et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer’s disease. Neuron. 2007;55:697–711.
   PubMed Web of Science ®Google Scholar
• Raymond CR, Ireland DR, Abraham WC. NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus. Brain Res. 2003;968:263–272.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li P, Feng J, et al. Dysfunction of NMDA receptors in Alzheimer’s disease. Neurol Sci. 2016;37:1039–1047.
   PubMed Web of Science ®Google Scholar
• Karthick C, Periyasamy S, Jayachandran KS, et al. Intrahippocampal administration of ibotenic acid induced cholinergic dysfunction via NR2A/NR2B expression: implications of resveratrol against Alzheimer disease pathophysiology. Front Mol Neurosci. 2016;9:28.
   PubMed Web of Science ®Google Scholar
• Holscher C, Gengler S, Gault VA, et al. Soluble beta-amyloid [25–35] reversibly impairs hippocampal synaptic plasticity and spatial learning. Eur J Pharmacol. 2007;561:85–90.
   PubMed Web of Science ®Google Scholar
• Brouillette J, Caillierez R, Zommer N, et al. Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-beta1–42 oligomers are revealed in vivo by using a novel animal model. J Neurosci. 2012;32:7852–7861.
   PubMed Web of Science ®Google Scholar
• Krysmann MJ, Castelletto V, Hamley IW. Fibrillisation of hydrophobically modified amyloid peptide fragments in an organic solvent. Soft Matter. 2007;3(11):14011406. .
   Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. Amsterdam: Elsevier; 2007. ISBN: 0123742439.
   Google Scholar
• Moorthi P, Premkumar P, Priyanka R, et al. Pathological changes in hippocampal neuronal circuits underlie age-associated neurodegeneration and memory loss: positive clue toward SAD. Neuroscience. 2015 20;301:90–105.
   PubMed Web of Science ®Google Scholar
• Ha TY, Chang KA, Kim J, et al. S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model. PLoS One. 2010 Jan 21;5(1):e8840. .
   PubMed Web of Science ®Google Scholar
• Hirano A, Zimmerman HM. Alzheimer’s neurofibrillary changes. A topographic study. Arch Neurol. 1962;7:227–242.
   PubMedGoogle Scholar
• Oz M, Lorke DE, Yang KS, et al. On the Interaction of β-Amyloid Peptides and α7-Nicotinic Acetylcholine Receptors in Alzheimer’s Disease. Curr Alzheimer Res. 2013;10(6):618–630.
   PubMed Web of Science ®Google Scholar
• Chambon C, Wegener N, Gravius A, et al. Behavioural and cellular effects of exogenous amyloid-beta peptides in rodents. Behav Brain Res. 2011;225:623–641.
   PubMed Web of Science ®Google Scholar
• Nilsson LN, Arendash GW, Leighty RE, et al. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiol Aging. 2004;25:1153–1167.
   PubMed Web of Science ®Google Scholar
• Shukla V, Zheng YL, Mishra SK, et al. A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer’s disease phenotypes in model mice. FASEB J. 2013;27:174–186.
   PubMed Web of Science ®Google Scholar
• Carroll JC, Rosario ER, Chang L, et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci. 2007;27:13357–13365.
   PubMed Web of Science ®Google Scholar
• Wong RS, Cechetto DF and Whitehead SN. Assessing the effects of acute amyloid β oligomer exposure in the rat. Int J Mol Sci. 2016;17:1390.
   PubMed Web of Science ®Google Scholar
• Nell HJ, Whitehead SN, Cechetto DF. Age-dependent effect of β-amyloid toxicity on basal forebrain cholinergic neurons and inflammation in the rat brain. Brain Pathol. 2015;25:531–542.
   PubMed Web of Science ®Google Scholar
• Viskontas IV, McAndrews MP, Moscovitch M. Remote episodic memory deficits in patients with unilateral temporal lobe epilepsy and excisions. J Neurosci. 2000;20(15):5853–5857.
   PubMed Web of Science ®Google Scholar
• Neves G, Cooke SF, Bliss TV. Synaptic plasticity, memory and the hippocampus: a neural network approach to casuality. Nat Rev Neurosci. 2008;9(1):65–75.
   PubMed Web of Science ®Google Scholar
• Faucher P, Mons N, Micheau J, et al. Hippocampal injections of oligomeric amyloid β- peptide (1–42) induce selective working memory deficits and long-lasting alterations of ERK signaling pathway. Front Aging Neurosci. 2016;7:245.
   PubMed Web of Science ®Google Scholar
• Kim JH, Anwyl R, Suh YH, et al. Use-dependent effects of amyloidogenic fragments of β-amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J Neurosci. 2001;21(4):1327–1333.
   PubMed Web of Science ®Google Scholar
• Niewoehner B, Single FN, Hvalby Ø, et al. Impaired spatial working memory but spared spatial reference memory following functional loss of NMDA receptors in the dentate gyrus. Eur J Neurosci. 2007;25(3):837–846.
   PubMed Web of Science ®Google Scholar
• Ornath MA, Hudry E, Boivin JR, et al. Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain. Mol Neurodegener. 2017;12:27.
   PubMed Web of Science ®Google Scholar
• Wang HY, Lee DHS, Davis CB, et al. Amyloid peptide Aβ1-42 binds selectively and with picomolar affinity to α7 nicotinic acetylcholine receptors. J Neurochem. 2000;75:1155–1161.
   PubMed Web of Science ®Google Scholar
• Engidawork E, Gulesserian T, Balic N, et al. Changes in nicotinic acetylcholine receptor subunits expression in brain of patients with down syndrome and Alzheimer’s disease. J Neural Transm Suppl. 2001;61:211–222.
   Google Scholar
• Ahmed T, Zahid S, Mahboob A, et al. Cholinergic system and post-translational modifications: an insight on the role in Alzheimer’s disease. Curr Neuropharmacol. 2017 May;15(4):480–494.
   PubMed Web of Science ®Google Scholar
• Kawahara M, Negishi-Kato M, Sadakane Y. Calcium dyshomeostasis and neurotoxicity of Alzheimer’s beta-amyloid protein. Expert Rev Neurother. 2009;9:681–693.
   PubMed Web of Science ®Google Scholar
• Echeverria V, Yarkov A, Aliev G. Positive modulators of the a7 nicotinic receptor against neuroinflammation and cognitive impairment in Alzheimer’s disease. Prog Neurobiol. 2016;144:142–157.
   PubMed Web of Science ®Google Scholar